Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 4/20 | 0.36 |
| ▸ | DRD3 | P35462 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8680434 | 0.98 | MEN1 (0.40) | MEN1KMT2ASIGMAR1DRD2DRD3 | |
| SCHEMBL9801281 | 0.90 | MEN1 (0.38) | MEN1KMT2ASIGMAR1DRD2DRD3 | |
| SCHEMBL9801673 | 0.89 | SIGMAR1 (0.49) | MEN1KMT2ASIGMAR1DRD2DRD3 | |
| SCHEMBL9801048 | 0.86 | MAPK1 (0.38) | MEN1KMT2ASIGMAR1DRD2DRD3 | |
| SCHEMBL9801806 | 0.86 | SIGMAR1 (0.38) | MEN1KMT2ASIGMAR1DRD2DRD3 | |
| SCHEMBL9801318 | 0.84 | KDM4E (0.36) | MEN1KMT2ASIGMAR1DRD2DRD3 | |
| SCHEMBL9801123 | 0.82 | KDM4E (0.35) | MEN1KMT2ASIGMAR1DRD2DRD3 | |
| SCHEMBL7095116 | 0.81 | — | — | |
| SCHEMBL13026698 | 0.81 | KDM4E (0.38) | MEN1KMT2ADRD2DRD3KDM4E | |
| SCHEMBL13026699 | 0.81 | KDM4E (0.38) | MEN1KMT2ADRD2DRD3KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062514-A1 | METHODS OF PREPARING ULTRA-LOW DENSITY SPRAY POLYURETHANE FOAM AND USES THEREOF | GENERAL COATINGS MFG CORP (US) | 2026-03-05 | — | — | US | claimed |
| US-10023683-B2 | Catalyst compositions for improving polyurethane foam performance | EVONIK DEGUSSA GMBH (DE) | 2018-07-17 | — | — | US | claimed |
| EP-2014695-B1 | Aliphatic polyester polymer compositions and preparation method thereof | IND TECH RES INST (TW) | 2011-05-04 | — | — | EP | claimed |
| US-7902303-B2 | Aliphatic polyester polymer compositions and preparation method thereof | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2011-03-08 | — | — | US | claimed |
| EP-1867669-B1 | Catalyst compositions for improving polyurethane foam performance | AIR PROD & CHEM (US) | 2008-11-26 | — | — | EP | claimed |
| US-7332225-B2 | Bonded vehicular glass assemblies utilizing two-component urethanes adhesive | DONNELLY CORPORATION (US) | 2008-02-19 | — | — | US | claimed |
| EP-1867669-A1 | Catalyst compositions for improving polyurethane foam performance | Air Products and Chemicals, Inc. (US) | 2007-12-19 | — | — | EP | claimed |
| US-20070287761-A1 | Catalyst compositions for improving polyurethane foam performance | EVONIK OPERATIONS GMBH (DE) | 2007-12-13 | — | — | US | claimed |
| US-20040214947-A1 | Bonded vehicular glass assemblies utilizing two-component urethanes adhesive | DONNELLY CORPORATION, A MICHIGAN CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-6353077-B2 | A WATER CURABLE ISOCYANATE FUNCTIONALIZED PREPOLYMER AND A FIRST AND SECOND CATALYST COMPONENT CHARACTERIZED IN THAT THE FIRST AMINE CATALYST IS COVALENTLY BOUND-IN TO THE PREPOLYMER AND SECOND CATALYST IS NOT CHEMICALLY BOUND | BSN MEDICAL, INC. | 2002-03-05 | — | — | US | claimed |
| US-5709737-A | AQUEOUS LIQUID VEHICLE, COLORANT, ALCOHOL ADDITIVE; SUITABLE FOR MICROWAVE DRYING PROCESSES | XEROX CORPORATION (US) | 1998-01-20 | — | — | US | claimed |
| JP-1139695-A | — | — | None | — | — | JP | disclosed |
| EP-4745170-A1 | METHOD FOR PREPARING A URETHANE GROUP-CONTAINING POLYMER | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4745169-A1 | COMPOSITION USEFUL AS COATING, SEALANT OR ADHESIVE | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-20260133508-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2026-05-14 | — | — | US | disclosed |
| US-3983139-A | 3-(Hydroxyhydrocarbylsecondaryamino)thiophene 1,1-dioxides and polyurethanes chain extended therewith | UNIROYAL INC. (US) | 1976-09-28 | — | — | US | disclosed |
| US-3983094-A | Thermally stable polyurethane elastomers produced from poly(oxypropylene)-poly(oxyethylene)glycols of high oxyethylene group content | UNIROYAL, INC. (US) | 1976-09-28 | — | — | US | disclosed |
| US-3956200-A | POLYGLYCOL HYDROGEN POLYPHOSPHONATE | STAUFFER CHEMICAL COMPANY (US) | 1976-05-11 | — | — | US | disclosed |
| US-3946038-A | CHAIN EXTENDERS FOR POLYURETHANES | UNIROYAL, INC. (US) | 1976-03-23 | — | — | US | disclosed |
| US-3933696-A | Polyalkylene glycol poly-phosphorus compounds in polyurethane foams | STAUFFER CHEMICAL COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260133508-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | SLC9A3, SLC9A1, HSPA4L | MEN1 4693/4885KMT2A 3385/4885SIGMAR1 1673/4885 |
| US-20260062514-A1 | METHODS OF PREPARING ULTRA-LOW DENSITY SPRAY POLYURETHANE FOAM AND USES THEREOF | FLI1, FIP1L1, FTO | MEN1 2302/4885KMT2A 644/4885SIGMAR1 773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.